NYSE · SRXH
Healthcare · Drug Manufacturers - General
$1.51
Down-$0.05 (-3.21%)
Updated Sep 8, 2026, 12:38 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
SRXH closed at $1.52 after 21 trading sessions, down 12.43% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 8, 2026 | $1.507 | $1.539 | $1.495 | $1.515 | 4.79K |
| Sep 4, 2026 | $1.56 | $1.565 | $1.49 | $1.51 | 354.05K |
| Sep 3, 2026 | $1.55 | $1.59 | $1.50 | $1.56 | 726.19K |
| Sep 2, 2026 | $1.61 | $1.6458 | $1.52 | $1.56 | 544.82K |
| Sep 1, 2026 | $1.66 | $1.70 | $1.59 | $1.63 | 674.32K |
| Aug 31, 2026 | $1.70 | $1.71 | $1.62 | $1.68 | 806.31K |
| Aug 28, 2026 | $1.77 | $1.78 | $1.7061 | $1.71 | 597.23K |
| Aug 27, 2026 | $1.84 | $2.015 | $1.75 | $1.75 | 1.4M |
| Aug 26, 2026 | $1.77 | $1.87 | $1.73 | $1.84 | 766.76K |
| Aug 25, 2026 | $1.82 | $1.84 | $1.76 | $1.80 | 592.88K |
| Aug 24, 2026 | $1.86 | $1.86 | $1.7731 | $1.81 | 393.99K |
| Aug 21, 2026 | $1.85 | $1.9399 | $1.8212 | $1.86 | 688.55K |
| Aug 20, 2026 | $1.86 | $1.88 | $1.7993 | $1.81 | 393.53K |
| Aug 19, 2026 | $1.78 | $1.8994 | $1.75 | $1.87 | 897.24K |
| Aug 18, 2026 | $1.84 | $1.93 | $1.76 | $1.79 | 1.04M |
| Aug 17, 2026 | $1.93 | $2.04 | $1.8301 | $1.89 | 1.2M |
| Aug 14, 2026 | $1.71 | $2.00 | $1.71 | $1.92 | 1.51M |
| Aug 13, 2026 | $1.82 | $1.845 | $1.67 | $1.83 | 1.65M |
| Aug 12, 2026 | $1.86 | $1.93 | $1.80 | $1.84 | 981.28K |
| Aug 11, 2026 | $1.75 | $1.89 | $1.6409 | $1.84 | 928.39K |
| Aug 10, 2026 | $1.56 | $1.79 | $1.56 | $1.73 | 1.64M |
The latest Smart Investors Daily articles mentioning SRXH.
SRXH research
Company profile and research snapshot.
SRX HealthSolutions Inc operates the continuing pet health and wellness business under the Halo brand, offering premium and super-premium foods, treats, toppers, chews, dental products and supplements for dogs and cats. The company provides high-quality pet products formulated to meet high-quality sourcing and nutritional standards and produced through co-manufacturing relationships. Its Consumer Products segment includes the legacy Halo pet food business with premium products such as dry kibble, wet food, freeze-dried raw food, treats and toppers. Products are sold across e-commerce platforms such as Amazon and Chewy, select retail partners, and international distributors, with operations mainly in the United States, Taiwan and other markets.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Aug 14, 2026
SRX Global Inc (SRXH) reports a 27% revenue increase and 52% cost reduction, while advancing its AI-driven digital asset strategy despite ongoing profitability challenges.
Benzinga · Aug 13, 2026
On Thursday, SRX HealthSolutions (AMEX:SRXH) discussed third-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive
Benzinga · Aug 13, 2026
SRX HealthSolutions (AMEX:SRXH) reported quarterly losses of $(0.36) per share. This is a 99.19 percent increase over losses of $(44.51) per share from the same period last year. The company reported $3.392 million in
Benzinga · Aug 4, 2026
The Company views Vistagen shares as undervalued and welcomes constructive engagement with its leadership team and Board of Directors to discuss ideas on how to unlock shareholder value.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SRXH.
